Drug research: myths, hype and reality
The DOI matches its Crossref record; 31 of the 32 references it cites were found in a registry or an index.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00129-0 · Cited by 18,139
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(96)00423-1 · Cited by 11,385
Molecular properties that influence the oral bioavailability of drug candidates
Veber, D. F., Johnson, S. R., Cheng, H.-Y., Smith, B. R., Ward, K. W., & Kopple, K. D. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm020017n · Cited by 8,420
Drug-like properties and the causes of poor solubility and poor permeability
Lipinski, C. A. (2000) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/s1056-8719(00)00107-6 · Cited by 3,734
Hopkins, A. L., & Groom, C. R. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd892 · Cited by 3,305
Ertl, P., Rohde, B., & Selzer, P. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm000942e · Cited by 3,084
ADMET in silico modelling: towards prediction paradise?
van de Waterbeemd, H., & Gifford, E. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1032 · Cited by 1,863
Molecular Complexity and Its Impact on the Probability of Finding Leads for Drug Discovery
Hann, M. M., Leach, A. R., & Harper, G. (2001) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci000403i · Cited by 877
The Design of Leadlike Combinatorial Libraries
Teague, S. J., Davis, A. M., Leeson, P. D., & Oprea, T. (1999) · Angewandte Chemie International Edition · doi:10.1002/(sici)1521-3773(19991216)38:24<3743::aid-anie3743>3.0.co;2-u · Cited by 870
Kelder, J., Grootenhuis, P. D. J., Bayada, D. M., Delbressine, L. P. C., & Ploemen, J.-P. (1999) · Pharmaceutical Research · doi:10.1023/a:1015040217741 · Cited by 813
Research works printed but not linked: 1
- Watson, J. D., with Berry, A. DNA. The Secret of Life. (William Heinemann, London, 2003).
Cited by
Items 301–353 of 353
Almeida, B., Mahajan, R., Kranzlmüller, D. A., Volkert, J. J., & Höfinger, S. (2005) · Lecture notes in computer science · doi:10.1007/11557265_55 · Cited by 1
Mertsch, K., Will, M., Czechtizky, W., Griesang, N., Marker, A., & Olsen, J. (2015) · doi:10.1002/9781118771723.ch13 · Cited by 1
Receptor Targets in Drug Discovery
Duzic, E., Marino, M. J., & Williams, M. J. (2010) · Wiley eBooks · doi:10.1002/0471266949.bmc029.pub2 · Cited by 1
The Application of PK/PD Modeling and Simulations During Lead Optimization
Friedrich, S. W., Lobo, E. D., Zimmerman, K., Borel, A. G., & Garner, C. O. (2007) · Springer eBooks · doi:10.1007/978-0-387-44961-6_15 · Cited by 1
Target- and System-based Strategies for Drug Discovery
Kenakin, T. (2006) · Elsevier eBooks · doi:10.1016/b978-012370599-0/50010-1
Busca de Inibidores Naturais Contra o Veneno de Apis Mellifera
Jorge, D. M. D. M. (2008) · doi:10.11606/d.17.2008.tde-29082013-152724
Visual Evaluation of Clustered Molecules in the Process of New Drugs Design
García, C. A., Therón, R., Peláez, R., López‐Pérez, J. L., & Santos‐García, G. (2009) · Lecture notes in computer science · doi:10.1007/978-3-642-02115-2_1
Dörwald, F. Z. (2012) · doi:10.1002/9783527645640.ch1
Silva, D. G. (2013) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
High Throughput Quantitative Mass Spectrometry
Williams, J. D., & Grant, R. P. (2012) · Encyclopedia of Drug Metabolism and Interactions · doi:10.1002/9780470921920.edm110
The discovery and development of drugs to treat psychiatric disorders: Historical perspective
Williams, M., & Barrett, J. E. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9780511980053.002
Dissolution of magnetically marked tablets: Investigations in a physical phantom
Biller, S., Domey, J., Fiedler, P., Holzhey, R., Richert, H., & Haueisen, J. (2012) · Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) · doi:10.1109/embc.2012.6346367
Drug Discovery in the Post-Genomic Era: Systems-Based Drug Discovery
Hu, Z. (2007) · International Conference on Bioinformatics and Biomedical Engineering · doi:10.1109/icbbe.2007.107
DRUGGABILITY OF SOME UNEXPLOITED PROTEINS OF MYCOPLASMA PNEUMONIAE M129
Al-Khafaji, Z. M., Zainib, H. A., Al-Rikabi, & Mahmood, M. B. (2017) · doi:10.13140/rg.2.2.14431.56480
Shaping the genohype: A cautionary tale of overpromise
Struve, S. (2015) · Summit (Simon Fraser University)
Hayeshi, R. K. (2012) · University of Zimbabwe Institutional Repository (University of Zimbabwe)
Tsaioun, K. (2014) · Royal Society of Chemistry eBooks · doi:10.1039/9781782620136-00110
Expanding the Target Space: Druggability Assessments
Schmidtke, P., Álvarez-García, D., Seco, J., & Barril, X. (2012) · Royal Society of Chemistry eBooks · doi:10.1039/9781849735377-00302
Navigating in Chemicobiological Space
Abad‐Zapatero, C. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-404635-1.00007-4
ADVANCES IN APPLICATIONS OF NANOTECHNOLOGY TO DRUG DELIVERY
Bellera, C. L., Enrique, A., Talevi, A., & Bruno‐Blanch, L. E. (2013) · Apple Academic Press eBooks · doi:10.1201/b16368-2
Williams, M. J. (2007) · Elsevier eBooks · doi:10.1016/b0-08-045044-x/09010-6
ADME Properties Leading to Toxicity
Tsaioun, K. (2016) · Wiley eBooks · doi:10.1002/9781119053248.ch7 · Cited by 1
Physicochemical Properties for Potential Alzheimer’s Disease Drugs
Ates-Alagoz, Z., & Adejare, A. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802810-0.00005-2
Modelos de virtual Screening de inibidores da cruzaína: desenvolvimento e validação experimental
Malvezzi, A. (2016) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.46.2016.tde-10082016-115529
The Polypharmacology Gap Between Chemical Biology and Drug Discovery
Antolín, A. A., & Mestres, J. (2017) · Royal Society of Chemistry eBooks · doi:10.1039/9781788010139-00349
Mass spectrometry methods for profiling xenobiotic distribution in biofluids and whole tissues
Swales, J. G. (2018) · Sheffield Hallam University · doi:10.7190/shu-thesis-00089
Target- and System-Based Strategies for Drug Discovery
Kenakin, T. (2009) · Elsevier eBooks · doi:10.1016/b978-0-12-374585-9.00010-4
Development, market authorization and market access of gene and cell-based therapies
ten Ham, R. M. T. (2021) · Utrecht University Repository (Utrecht University) · doi:10.33540/612
Silber, K. (2007) · Publikationsserver (Universitat Marburg) · doi:10.17192/z2007.0753
Sadhasivam, G. (2020) · Asian Journal of Organic & Medicinal Chemistry · doi:10.14233/ajomc.2020.ajomc-p288
(2009) · Wiley eBooks · doi:10.1002/9780470551455.biblio
Williams, M. (2007) · xPharm: The Comprehensive Pharmacology Reference · doi:10.1016/b978-008055232-3.60061-3
The Rational Design of Biological Complexity: A Deceptive Metaphor
Regenmortel, M. H. V. V. (2019) · Springer eBooks · doi:10.1007/978-3-030-32459-9_8 · Cited by 2
Baum, B., Dey, G., & Ramkumar, N. (2018) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.734027260.793551733
Mechanistic Research for the Student or Educator (Part II of II)
Leak, R. K., & Schreiber, J. B. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.741492
Utilizing a Cell-free Protein Synthesis Platform for Natural Product SynthesisPreprint
Ditzel, A., Zhao, F., Gao, X., & Phillips, G. N. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.07.22.501086
Kenakin, T. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-99289-3.00006-3
Drug discovery: Standing on the shoulders of giants
Miller, S. M., Moos, W. H., Munk, B. H., Munk, S. A., Hart, C. P., & Spellmeyer, D. C. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-824304-6.00001-8
Cabrera‐Pérez, M. Á., Bermejo-Sanz, M., González‐Álvarez, M., González‐Álvarez, I., Lara, V. V., & Chou, W.-H. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15510-9.00017-7
Wilson, I. D., Rainville, P. D., Gethings, L. A., Hancock, P., Trengove, R. D., & Plumb, R. S. (2024) · Journal of Chromatography A · doi:10.1016/j.chroma.2024.465292
Exploring the potential of artificial intelligence in drug delivery to brain
Mehla, S., Arya, G. C., & Arora, V. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13474-6.00023-8 · Cited by 1
Physicochemical properties for potential Alzheimer's disease drugs
Gado, S., Ateş‐Alagöz, Z., & Adejare, A. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-30008-0.00017-x
Kontijevskis, A. (2008) · DiVA (Digitala Vetenskapliga Arkivet)
Predicting target and chemical druggability
Oprea, T. I., & Avram, S. I. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-29808-0.00084-4 · Cited by 1
Organ-on-a-chip: a microfluidic system of next frontier in medicine
Nori, L. P., Bhanumounika, S., & Seethamraju, S. M. (2026) · SA pharmaceutical journal. · doi:10.36303/sapj.3398
BindingDB (2013) · UC San Diego · doi:10.7270/q2q81f2j
BindingDB (2024) · UC San Diego · doi:10.7270/q2571h6v
Development and application of NMR methods for challenges in drug discovery
Pilger, J. (2013) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-3829
Metadata
- Authors
- Kubinyi, H.
- Corresponding author
- Kubinyi, Hugo
- Venue
- Nature Reviews Drug Discovery
- Published
- 2003-08
- Volume
- 2
- Issue
- 8
- Pages
- 665-668
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W1487233798
- Cited by
- 348
- References
- 32
- Citations by year
- 2026: 3 · 2025: 3 · 2024: 13 · 2023: 6 · 2022: 9 · 2021: 4 · 2020: 9 · 2019: 16 · 2018: 24 · 2017: 8 · 2016: 15 · 2015: 17 · 2014: 16 · 2013: 17 · 2012: 26
- FWCI
- 1.69
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Drug Discovery (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Physical Sciences › Chemistry › Organic Chemistry › Chemical Synthesis and Analysis
- Physical Sciences › Chemistry › Organic Chemistry › Synthesis and Characterization of Heterocyclic Compounds
- Keywords
- drug discovery, lead-like compounds, drug-like molecules, oral bioavailability, combinatorial chemistry, high-throughput screening, ADME, computer-aided drug design, structure-based drug design, lead optimization, medicinal chemistry
- MeSH terms
- Chemistry, Pharmaceutical, Humans, Pharmacokinetics, Pharmacology, Research, Technology, Pharmaceutical
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.